• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22754 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Agency for Healthcare Research and Quality (AHRQ) Update on horizon scans of genetic tests currently available for clinical use in cancers
2013     Agency for Healthcare Research and Quality (AHRQ) Update on emerging genetic tests currently available for clinical use in common cancers
2005     Agency for Healthcare Research and Quality (AHRQ) Update on acute bacterial rhinosinusitis
2012     Belgian Health Care Knowledge Centre (KCE) Update of the national guideline on upper gastrointestinal cancer
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for the introduction of new drugs (GINF)
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for the acquisition of new technologies
2016     Andalusian Health Technology Assessment Area (AETSA) Update of the Guide for decision-making on the introduction of new genetic tests in the National Health System (GEN Guide)
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for acquisition of new technologies (GANT)
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guidance for the introduction of new drugs
2022     Agency for Care Effectiveness (ACE) Update of MOH list of subsidised drugs to include treatments for various cancer conditions
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
2020     National Institute for Health and Care Excellence (NICE) Upadacitinib for treating severe rheumatoid arthritis. NICE technology appraisal guidance 665
2023     National Institute for Health and Care Excellence (NICE) Upadacitinib for treating moderately to severely active ulcerative colitis. NICE technology appraisal guidance 856
2021     National Institute for Health and Care Excellence (NICE) Upadacitinib for treating moderate rheumatoid arthritis. NICE technology appraisal guidance 744
2022     National Institute for Health and Care Excellence (NICE) Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs. NICE technology appraisal guidance 768
2023     National Institute for Health and Care Excellence (NICE) Upadacitinib for treating active non-radiographic axial spondyloarthritis. NICE technology appraisal guidance 861
2022     National Institute for Health and Care Excellence (NICE) Upadacitinib for treating active ankylosing spondylitis. NICE technology appraisal guidance 829
2021     Scottish Medicines Consortium (SMC) Upadacitinib for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs)
2023     National Institute for Health and Care Excellence (NICE) Upadacitinib for previously treated moderately to severely active Crohn's disease. NICE technology appraisal guidance 905
2022     Institute for Clinical and Economic Review (ICER) Unsupported price increase report: unsupported price increases occurring in 2021
2010     National Institute for Health and Care Excellence (NICE) Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction
2022     NIHR Health Technology Assessment programme Unspecified living kidney donation in the UK: barriers to implementation and delivery
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2002     Health Council of the Netherlands Gezondheidsraad (GR) Universal vaccinations against meningococcal serogroup C and Pneumococcal disease - systematic review, expert panel
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2008     Agency for Healthcare Research and Quality (AHRQ) Universal newborn hearing screening: systematic review to update the 2001 U.S. Preventive Services Task Force recommendation
2004     The Swedish Council on Health Technology Assessment (SBU) Universal newborn hearing screening - early assessment briefs (Alert)
2008     Adelaide Health Technology Assessment (AHTA) Universal neonatal hearing screening
2007     Andalusian Health Technology Assessment Area (AETSA) Universal leukorreduction. A systematic review of the literature and an economic assessment
2021     NIHR Health Technology Assessment programme Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2014     NIHR Health Technology Assessment programme United Kingdom Oscillation Study: long-term outcomes of a randomised trial of two modes of neonatal ventilation
2007     Adelaide Health Technology Assessment (AHTA) Unispacer: for the treatment of unicompartmental osteoarthritis. Horizon scanning report
2022     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Unipercare service for home care and service centres
2008     HAYES, Inc. Uniparental disomy (UPD) for chromosomes 6, 7, 11, 14, or 15
2018     National Institute for Health and Care Excellence (NICE) Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease. NICE interventional procedures guidance 606
2002     HAYES, Inc. Unicompartmental knee replacement surgery
2005     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44.
2004     Adelaide Health Technology Assessment (AHTA) Uni-Gold (TM) Recombigen (R) HIV test to detect antibodies to HIV-1 in the plasma and whole blood of individuals at risk of HIV infection
2001     University of York Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews
1996     University of York Undertaking systematic reviews of research on effectiveness: CRD guidelines for those carrying out or commissioning reviews
2024     NIHR Health Technology Assessment programme Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme
2023     NIHR Health Services and Delivery Research programme Understanding what affects psychological morbidity in informal carers when providing care at home for patients at the end of life: a systematic qualitative evidence synthesis
2018     NIHR Health Technology Assessment programme Understanding variation in ambulance service non-conveyance rates: a mixed methods study
2016     NIHR Health Technology Assessment programme UNderstanding uptake of Immunisations in TravellIng aNd Gypsy communities (UNITING): a qualitative interview study
2016     NIHR Health Technology Assessment programme UnderstaNding uptake of Immunisations in TravellIng aNd Gypsy communities (UNITING) A qualitative interview study
2022     NIHR Health Services and Delivery Research programme Understanding the potential factors affecting carers’ mental health during end-of-life home care: a meta synthesis of the research literature
2020     NIHR Public Health Research (PHR) programme Understanding the impact of tobacco tax increases and tobacco industry pricing on smoking behaviours and inequalities
2020     NIHR Health Technology Assessment programme Understanding the health-care experiences of people with sickle cell disorder transitioning from paediatric to adult services: This Sickle Cell Life, a longitudinal qualitative study
2018     NIHR Health Services and Delivery Research programme Understanding new models of integrated care in developed countries: a systematic review
2018     NIHR Health Services and Delivery Research programme Understanding new models of care in local contexts: a systematic review using frameworks to examine pathways of change, applicability, and generalisability of the international research evidence
2020     NIHR Health Services and Delivery Research programme Understanding how frontline staff use patient experience data for service improvement - an exploratory case study evaluation and national survey (US-PEx)
2021     NIHR Health Technology Assessment programme Understanding health-care outcomes of older people with cognitive impairment and/or dementia admitted to hospital: a mixed-methods study
2018     NIHR Health Services and Delivery Research programme Understanding employee whistleblowing in health care
2020     NIHR Health Services and Delivery Research programme Understanding and improving experiences of care in hospital for people living with dementia, their carers and staff: three systematic reviews
2019     NIHR Health Services and Delivery Research programme Understanding and enhancing how hospital staff learn from and act on patient experience data
1990     U. S. Congress. Office of Technology Assessment (OTA) Unconventional cancer treatments
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Uncomplicated senile cataract surgeries in Alberta
2010     Adelaide Health Technology Assessment (AHTA) Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium/vilanterol (as trifenatate) (Anoro® Ellipta®)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Umeclidinium and vilanterol for chronic obstructive pulmonary disease
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium (Incruse®)
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Umbilical cord clamp removal: a review of the clinical benefits and harms
2013     HAYES, Inc. Umbilical cord blood stem cell transplantation for hematological cancers and nonmalignant disorders in children
2013     HAYES, Inc. Umbilical cord blood stem cell transplantation for hematological and lymphoid malignancies in adults
2005     HAYES, Inc. Umbilical cord blood stem cell transplantation
2002     HAYES, Inc. Umbilical cord blood stem cell transplantation
2011     HAYES, Inc. Ultroid hemorrhoid management system (Ultroid Technologies Inc.)
2009     Medical Advisory Secretariat (MAS) Ultraviolet phototherapy management of moderate-to-severe plaque psoriasis: an evidence-based analysis
2013     Malaysian Health Technology Assessment (MaHTAS) Ultraviolet Germicidal Irradiation (UVGI) indoor purifier – an update
2010     HAYES, Inc. Ultraviolet B phototherapy for vitiligo
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound-guided sclerotherapy with foam in chronic vein insufficiency
2001     HAYES, Inc. Ultrasound-guided percutaneous breast biopsy
2012     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2014     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2019     National Institute for Health and Care Excellence (NICE) Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids. NICE interventional procedures guidance 657
2016     HAYES, Inc. Ultrasound-guided high-intensity focused ultrasound for primary treatment of localized prostate cancer
2006     National Institute for Health and Care Excellence (NICE) Ultrasound-guided foam sclerotherapy for varicose veins
2007     National Institute for Health and Care Excellence (NICE) Ultrasound-guided foam sclerotherapy for varicose veins
2011     HAYES, Inc. Ultrasound-Guided Foam Sclerotherapy (UGFS) for varicose veins
2007     HAYES, Inc. Ultrasound-enhanced transcutaneous drug delivery
1999     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound-assisted lipoplasty
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
1997     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Ultrasound treatment - systematic review
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Ultrasound treatment - nonunion fractures
2014     HAYES, Inc. Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
2003     ECRI Ultrasound screening of normal-risk women for prevention of postterm pregnancy
2000     NIHR Health Technology Assessment programme Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views
2003     Adelaide Health Technology Assessment (AHTA) Ultrasound screening for hip dysplasia: a new screening programme for the early detection of hip dysplasia in neonates
2006     Medical Advisory Secretariat (MAS) Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis
2001     Centre for Clinical Effectiveness (CCE) Ultrasound or venogram for diagnosis of deep vein thrombosis (DVT)?
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound of peripheral nerves
2004     Malaysian Health Technology Assessment Unit (MHTAU) Ultrasound in primary and antenatal care
2004     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Ultrasound in pregnancy - Evaluation of the routine ultrasound examinations according to the German Maternity Code
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound imaging in the practice of anaesthesia
2012     HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines
2007     Adelaide Health Technology Assessment (AHTA) Ultrasound for assessment of risk of fracture
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Ultrasound diagnostic during pregnancy
2003     Institute for Clinical Systems Improvement (ICSI) Ultrasound cervical length for the prediction of preterm labor
2015     HAYES, Inc. Ultrasound bone growth stimulation